Dolutegravir drug-resistance monitoring in Africa

Lancet HIV. 2021 Nov;8(11):e664-e666. doi: 10.1016/S2352-3018(21)00268-X.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Drug Resistance, Viral
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • HIV Integrase Inhibitors* / pharmacology
  • HIV Integrase Inhibitors* / therapeutic use
  • Heterocyclic Compounds, 3-Ring / therapeutic use
  • Humans
  • Oxazines / therapeutic use
  • Piperazines
  • Pyridones / therapeutic use

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir